LONDON (Alliance News) - Yourgene Health PLC on Tuesday said it launched the Sage 32 plex test, a new high-throughput, non-invasive prenatal testing and analysis solution for clinical laboratories.
The molecular diagnostics company said Sage 32 plex uses the latest technology to detect placental DNA in a maternal blood sample, enabling pregnant women to get fast, safe and reliable test results.
The Sage 32 plex solution significantly improves efficiency, enabling up to 32 samples to be processed in one sequencing run, compared with just 12 samples previously. Yourgene said this will provide laboratories with enhanced flexibility, scalability and cost-effectiveness.
Yourgene provides two complementary screening solutions, Sage and the IONA test, to meet the requirements of laboratory customers, clinicians and pregnant women across different international locations.
The Sage prenatal screen difference from the IONA test in that it offers screening on a wider range of clinical conditions, Yourgene explained.
"This latest product launch from Yourgene is an important enhancement of our Sage solution," said Chief Executive Lyn Rees.
"With Sage 32 plex, we are almost trebling the throughput, making it a highly efficient solution for our international laboratory network which we are very excited to commercialise," added Rees.
Yourgene shares were trading 0.6% lower on Tuesday at 9.40 pence each.